These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21757934)

  • 21. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil.
    Kaji Y; Wada A; Imaoka I; Matsuo M; Terachi T; Kobashi Y; Sugimura K; Fujii M; Maruyama K; Takizawa O
    J Magn Reson Imaging; 2002 Dec; 16(6):697-706. PubMed ID: 12451583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.
    Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK
    BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.
    Giusti S; Caramella D; Fruzzetti E; Lazzereschi M; Tognetti A; Bartolozzi C
    Abdom Imaging; 2010 Dec; 35(6):757-63. PubMed ID: 19756851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
    Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer.
    Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Lisi D; Osimani M; Alfarone A; Gentilucci A; Parente U; Passariello R; Gentile V
    Cancer Invest; 2010 May; 28(4):424-32. PubMed ID: 20073578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
    Ma C; Chen L; Scheenen TW; Lu J; Wang J
    Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
    Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
    BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
    Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
    Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging.
    Casciani E; Gualdi GF
    Abdom Imaging; 2006; 31(4):490-9. PubMed ID: 16955379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Magnetic resonance with an endorectal coil and a fast spin echo sequence in the staging of prostatic carcinoma. The correlation with histopathological data].
    Masi A; Olmastroni M; Marin E; Consalvo M; Lascialfari L; Ricupero L; Nicita G; Villari D; Amorosi A; Villari N
    Radiol Med; 1997 Nov; 94(5):496-502. PubMed ID: 9465216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
    Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
    Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
    Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
    J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
    Créhange G; Parfait S; Liegard M; Maingon P; Ben Salem D; Cochet A; Funes de la Vega M; Cormier L; Bonnetain F; Mirjolet C; Brunotte F; Walker PM
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1087-94. PubMed ID: 20615624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results].
    Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B
    Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
    Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level.
    Pickett B; Kurhanewicz J; Pouliot J; Weinberg V; Shinohara K; Coakley F; Roach M
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):65-72. PubMed ID: 16517094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI spectroscopy in screening of prostate cancer.
    Goeb K; Engehausen DG; Krause FS; Hollenbach HP; Niedobitek G; Buettner M; Frangou P; Engelhard K
    Anticancer Res; 2007; 27(1B):687-93. PubMed ID: 17348461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
    Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
    Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
    Arteaga de Castro CS; Boer VO; Luttje MP; van der Velden TA; Bhogal A; van Vulpen M; Luijten PR; van der Heide UA; Klomp DW
    NMR Biomed; 2014 Nov; 27(11):1353-60. PubMed ID: 25212868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.